BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25226428)

  • 1. Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancer.
    Chen AB; Li L; Cronin A; Schrag D
    J Thorac Oncol; 2014 Dec; 9(12):1788-95. PubMed ID: 25226428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.
    Harris JP; Murphy JD; Hanlon AL; Le QT; Loo BW; Diehn M
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):872-84. PubMed ID: 24495591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer.
    Kale MS; Mhango G; Bonomi M; Federman A; Sigel K; Rosenzweig KE; Wisnivesky JP
    Ann Am Thorac Soc; 2016 Sep; 13(9):1593-9. PubMed ID: 27299697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
    Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
    Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
    Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
    Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
    Sher DJ; Koshy M; Liptay MJ; Fidler MJ
    Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
    Sher DJ; Neville BA; Chen AB; Schrag D
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques.
    Jairam V; Pasha S; Soulos PR; Gross CP; Yu JB; Park HS; Decker RH
    Lung Cancer; 2021 Nov; 161():171-179. PubMed ID: 34607209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.
    Shirvani SM; Jiang J; Gomez DR; Chang JY; Buchholz TA; Smith BD
    Lung Cancer; 2013 Nov; 82(2):252-9. PubMed ID: 24018022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
    Lin SH; Zhang N; Godby J; Wang J; Marsh GD; Liao Z; Komaki R; Ho L; Hofstetter WL; Swisher SG; Mehran RJ; Buchholz TA; Elting LS; Giordano SH
    Cancer; 2016 Mar; 122(6):917-28. PubMed ID: 26716915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of primary chemoradiotherapy in clinical stage III non-small cell lung cancer: intensity-modulated radiotherapy versus 3D conformal radiotherapy.
    Hsia TC; Tu CY; Chen HJ; Chen SC; Liang JA; Chen CY; Wang YC; Chien CR
    Anticancer Res; 2014 Sep; 34(9):5175-80. PubMed ID: 25202111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Flattening Filter Free on Three-dimensional Conformal Radiation Therapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT) Plans for Metastatic Brain Tumors from Non-small Cell Lung Cancer.
    Shi LW; Lai YQ; Lin Q; Ha HM; Fu LR
    Health Phys; 2015 Jul; 109(1):1-9. PubMed ID: 26011493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.
    Crandley EF; Hegarty SE; Hyslop T; Wilson DD; Dicker AP; Showalter TN
    Cancer Med; 2014 Apr; 3(2):397-405. PubMed ID: 24519910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.
    Amini A; Morgan R; Meyer E; Fakhoury K; Ladbury C; Bickett T; McDermott JD; Stokes W; Karam SD
    Head Neck; 2021 Nov; 43(11):3393-3403. PubMed ID: 34382714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
    Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non-Small Cell Lung Cancer.
    Yu B; Jun Ma S; Waldman O; Dunne-Jaffe C; Chatterjee U; Turecki L; Gill J; Yendamuri K; Iovoli A; Farrugia M; Singh AK
    JAMA Netw Open; 2022 Sep; 5(9):e2230704. PubMed ID: 36074462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.
    Wang EH; Rutter CE; Corso CD; Decker RH; Wilson LD; Kim AW; Yu JB; Park HS
    J Thorac Oncol; 2015 Jun; 10(6):937-43. PubMed ID: 25738221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer.
    Yu JB; Soulos PR; Sharma R; Makarov DV; Decker RH; Smith BD; Desai RA; Cramer LD; Gross CP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e101-7. PubMed ID: 22342095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.